Eli Lilly slashed insulin prices. This starts a race to the bottom.

Drug pricing experts believe that initiatives to bring lower-cost insulin to market could become a race to the bottom on insulin prices.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...